| Primary |
| Product Used For Unknown Indication |
38.3% |
| Chronic Obstructive Pulmonary Disease |
27.6% |
| Asthma |
24.7% |
| Dyspnoea |
1.9% |
| Respiratory Disorder |
1.6% |
| Emphysema |
1.4% |
| Bronchitis |
0.6% |
| Hypertension |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Lung Disorder |
0.5% |
| Bronchitis Chronic |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Wheezing |
0.3% |
| Cough |
0.2% |
| Diabetes Mellitus |
0.2% |
| Multiple Allergies |
0.2% |
| Pulmonary Fibrosis |
0.2% |
| Blood Pressure |
0.2% |
| Bronchiectasis |
0.2% |
| Hiv Infection |
0.2% |
|
| Product Quality Issue |
14.1% |
| Death |
13.2% |
| Pneumonia |
12.7% |
| Hospitalisation |
12.4% |
| Dyspnoea |
5.8% |
| Chronic Obstructive Pulmonary Disease |
4.5% |
| Wheezing |
4.2% |
| Treatment Noncompliance |
3.7% |
| Asthma |
3.3% |
| Lung Neoplasm Malignant |
3.3% |
| Throat Irritation |
2.7% |
| Underdose |
2.7% |
| Investigation |
2.6% |
| Surgery |
2.4% |
| Neoplasm Malignant |
2.3% |
| Cerebrovascular Accident |
2.2% |
| Malaise |
2.2% |
| Myocardial Infarction |
2.0% |
| Drug Ineffective |
1.9% |
| Drug Administration Error |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
39.2% |
| Asthma |
22.2% |
| Chronic Obstructive Pulmonary Disease |
17.0% |
| Emphysema |
6.3% |
| Dyspnoea |
1.7% |
| Hypertension |
1.7% |
| Respiratory Disorder |
1.5% |
| Sleep Disorder |
1.5% |
| Depression |
1.2% |
| Prophylaxis |
1.1% |
| Bronchitis |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hiv Infection |
0.7% |
| Atrial Fibrillation |
0.6% |
| Benign Prostatic Hyperplasia |
0.6% |
| Synovial Cyst |
0.6% |
| Paraesthesia |
0.5% |
| Anxiety |
0.4% |
| Arthralgia |
0.4% |
|
| Asthma |
12.3% |
| Wheezing |
10.2% |
| Dyspnoea |
7.0% |
| Pneumonia |
7.0% |
| Weight Increased |
7.0% |
| Weight Decreased |
6.4% |
| Drug Hypersensitivity |
5.9% |
| Tremor |
5.9% |
| Urticaria |
5.9% |
| Product Quality Issue |
4.3% |
| Hospitalisation |
3.7% |
| Respiratory Failure |
3.7% |
| Throat Irritation |
3.2% |
| Drug Ineffective |
2.7% |
| Migraine |
2.7% |
| Pruritus |
2.7% |
| Respiratory Disorder |
2.7% |
| Vision Blurred |
2.7% |
| Headache |
2.1% |
| Lung Disorder |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.8% |
| Asthma |
13.7% |
| Chronic Obstructive Pulmonary Disease |
12.9% |
| Hypertension |
4.7% |
| Rheumatoid Arthritis |
3.5% |
| Pain |
3.1% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Depression |
2.3% |
| Hypersensitivity |
1.9% |
| Emphysema |
1.8% |
| Anxiety |
1.8% |
| Crohn's Disease |
1.8% |
| Pulmonary Arterial Hypertension |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Osteoporosis |
1.6% |
| Diabetes Mellitus |
1.6% |
| Dyspnoea |
1.2% |
| Drug Use For Unknown Indication |
1.1% |
| Hypothyroidism |
1.1% |
| Atrial Fibrillation |
1.1% |
|
| Vomiting |
10.0% |
| Product Quality Issue |
8.8% |
| Pneumonia |
8.6% |
| Dyspnoea |
7.4% |
| Weight Decreased |
6.5% |
| Wheezing |
6.1% |
| Drug Ineffective |
5.8% |
| Pulmonary Embolism |
5.8% |
| Weight Increased |
4.9% |
| Pain |
4.4% |
| Incorrect Route Of Drug Administration |
4.2% |
| Sinusitis |
3.7% |
| Death |
3.3% |
| Nausea |
3.1% |
| Off Label Use |
3.0% |
| Tremor |
3.0% |
| Pain In Extremity |
3.0% |
| Rash |
3.0% |
| Injection Site Pain |
2.8% |
| Oedema Peripheral |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
51.7% |
| Antiretroviral Therapy |
27.6% |
| Chronic Obstructive Pulmonary Disease |
6.9% |
| Hiv Infection |
6.9% |
| Infection Prophylaxis |
3.4% |
| Pulmonary Function Test Decreased |
3.4% |
|
| Weight Increased |
66.7% |
| Obstructive Airways Disorder |
33.3% |
|
